Knowledge-based classification of fine-grained immune cell types in single-cell RNA-Seq data.


Journal

Briefings in bioinformatics
ISSN: 1477-4054
Titre abrégé: Brief Bioinform
Pays: England
ID NLM: 100912837

Informations de publication

Date de publication:
02 09 2021
Historique:
received: 05 10 2020
revised: 11 01 2021
accepted: 27 01 2021
pubmed: 9 3 2021
medline: 20 11 2021
entrez: 8 3 2021
Statut: ppublish

Résumé

Single-cell RNA sequencing (scRNA-Seq) is an emerging strategy for characterizing immune cell populations. Compared to flow or mass cytometry, scRNA-Seq could potentially identify cell types and activation states that lack precise cell surface markers. However, scRNA-Seq is currently limited due to the need to manually classify each immune cell from its transcriptional profile. While recently developed algorithms accurately annotate coarse cell types (e.g. T cells versus macrophages), making fine distinctions (e.g. CD8+ effector memory T cells) remains a difficult challenge. To address this, we developed a machine learning classifier called ImmClassifier that leverages a hierarchical ontology of cell type. We demonstrate that its predictions are highly concordant with flow-based markers from CITE-seq and outperforms other tools (+15% recall, +14% precision) in distinguishing fine-grained cell types with comparable performance on coarse ones. Thus, ImmClassifier can be used to explore more deeply the heterogeneity of the immune system in scRNA-Seq experiments.

Identifiants

pubmed: 33681983
pii: 6157454
doi: 10.1093/bib/bbab039
pmc: PMC8536868
pii:
doi:

Substances chimiques

RNA 63231-63-0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States
Organisme : NCI NIH HHS
ID : U54 CA209978
Pays : United States

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Références

Cell. 2018 Nov 1;175(4):998-1013.e20
pubmed: 30388456
Nat Commun. 2020 Apr 14;11(1):1818
pubmed: 32286268
Clin Cancer Res. 2014 Oct 1;20(19):5064-74
pubmed: 24714771
Immunity. 2018 Feb 20;48(2):214-226
pubmed: 29466754
Nat Methods. 2014 Jul;11(7):740-2
pubmed: 24836921
Nat Methods. 2018 May;15(5):359-362
pubmed: 29608555
JCI Insight. 2018 Dec 6;3(23):
pubmed: 30518681
Bioinformatics. 2003 Oct;19 Suppl 2:ii42-9
pubmed: 14534170
Nat Methods. 2019 Oct;16(10):983-986
pubmed: 31501545
Science. 2016 Apr 8;352(6282):189-96
pubmed: 27124452
Immunity. 2019 May 21;50(5):1317-1334.e10
pubmed: 30979687
Nat Methods. 2019 Oct;16(10):1007-1015
pubmed: 31501550
Bioinformatics. 2012 Mar 15;28(6):882-3
pubmed: 22257669
Nat Immunol. 2019 Feb;20(2):163-172
pubmed: 30643263
Bioinformatics. 2017 Apr 15;33(8):1210-1215
pubmed: 28052928
J Immunol. 2018 Oct 1;201(7):1813-1815
pubmed: 30224359
Nat Methods. 2017 Sep;14(9):865-868
pubmed: 28759029
Cell. 2018 Aug 23;174(5):1293-1308.e36
pubmed: 29961579
Cell. 2011 Jan 21;144(2):296-309
pubmed: 21241896
Exp Hematol. 2018 Dec;68:51-61
pubmed: 30243574
Immunol Today. 2000 Nov;21(11):573-83
pubmed: 11094262
Nat Biotechnol. 2018 Jun;36(5):411-420
pubmed: 29608179
Genome Biol. 2019 Sep 9;20(1):194
pubmed: 31500660
NAR Genom Bioinform. 2020 Apr 20;2(2):lqaa025
pubmed: 33575582
Cancer Immunol Res. 2018 Nov;6(11):1388-1400
pubmed: 30266715
Nucleic Acids Res. 2019 Sep 19;47(16):e95
pubmed: 31226206
Nat Rev Drug Discov. 2016 Mar;15(3):204-16
pubmed: 26669673
Cell. 2017 Dec 14;171(7):1611-1624.e24
pubmed: 29198524
Nat Protoc. 2018 Apr;13(4):599-604
pubmed: 29494575
Cell. 2017 Jun 15;169(7):1342-1356.e16
pubmed: 28622514
Nat Rev Immunol. 2018 Jan;18(1):35-45
pubmed: 28787399
Nature. 2018 Feb 22;554(7693):555-557
pubmed: 29469107
Genes (Basel). 2019 Jul 12;10(7):
pubmed: 31336988
Nat Rev Genet. 2019 May;20(5):273-282
pubmed: 30617341
Nat Immunol. 2013 Oct;14(10):1014-22
pubmed: 24048123

Auteurs

Xuan Liu (X)

Department of Integrative Biology & Pharmacology, University of Texas Health Science Center at Houston, Houston, TX 77030, USA.

Sara J C Gosline (SJC)

Sage Bionetworks, Seattle, WA 98109, USA.

Lance T Pflieger (LT)

Department of Medical Oncology & Therapeutics Research, City of Hope National Medical Center, Duarte, CA 91010, USA.

Pierre Wallet (P)

Department of Medical Oncology & Therapeutics Research, City of Hope National Medical Center, Duarte, CA 91010, USA.

Archana Iyer (A)

Center for Cancer Systems Immunology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.

Justin Guinney (J)

Sage Bionetworks, Seattle, WA 98109, USA.

Andrea H Bild (AH)

Department of Medical Oncology & Therapeutics Research, City of Hope National Medical Center, Duarte, CA 91010, USA.

Jeffrey T Chang (JT)

Department of Integrative Biology & Pharmacology, University of Texas Health Science Center at Houston, Houston, TX 77030, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH